T43.622A Poisoning by amphetamines, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by amphetamines, intentional self-harm, initial encounter

Summary

This condition describes toxic effects resulting from the intentional self-harm ingestion or exposure to amphetamines during an initial medical encounter. Amphetamines are central nervous system stimulants, and this code applies to cases where self-directed exposure leads to poisoning requiring acute medical evaluation and management.

Causes

Intentional self-harm poisoning may occur due to deliberate ingestion of amphetamines, including prescription medications (e.g., for ADHD or narcolepsy) or illicit forms. This includes scenarios where the substance was taken with the intent to cause harm, such as overdose or self-poisoning.

Risk Factors

• History of suicidal ideation or prior self-harm behaviors.
• Co-occurring mental health conditions (e.g., depression, anxiety, or substance use disorders).
• Access to amphetamine medications or illicit substances.
• Acute stressors or crises increasing impulsive behavior.

Symptoms

• Severe agitation, restlessness, or hyperactivity.
• Tachycardia, hypertension, or palpitations.
• Tremors, muscle rigidity, or seizures.
• Nausea, vomiting, or abdominal pain.
• Hallucinations, paranoia, or psychosis.
• Altered mental status, including confusion or coma.

Diagnosis

Diagnosis relies on clinical evaluation, including patient history (if available), physical examination, and laboratory testing. Toxicology screens may confirm amphetamine exposure. Documentation of intentional self-harm and initial encounter status is critical for accurate coding.

Treatment Options

Management focuses on stabilizing the patient, with interventions such as airway support, cardiovascular monitoring, and administration of sedatives or antipsychotics as needed. Activated charcoal may be used if ingestion was recent. Psychiatric evaluation and crisis intervention are essential components of care.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying mental health status. Follow-up includes monitoring for complications, psychiatric assessment, and referral to mental health services. Long-term outcomes vary based on individual circumstances and support systems.

Complications

• Cardiovascular events (e.g., arrhythmias, myocardial infarction).
• Neurological damage (e.g., seizures, cerebral edema).
• Rhabdomyolysis or kidney injury.
• Psychiatric sequelae (e.g., persistent anxiety or depression).

Lifestyle & Prevention

• Secure storage of prescription medications to prevent access.
• Education on the risks of amphetamine misuse and self-harm.
• Access to mental health resources and crisis support.
• Avoidance of illicit substance use.

When to Seek Professional Help

Seek immediate medical attention if there is suspected intentional self-harm or poisoning, especially with symptoms like severe agitation, chest pain, seizures, or altered consciousness. Prompt care is critical to reduce morbidity and mortality.

Tips for Medical Coders

Document the intent (intentional self-harm), encounter type (initial), and substance (amphetamines) clearly. Ensure clinical notes support the diagnosis and align with the code’s specificity. Verify that the encounter is the first for this poisoning episode to justify the "initial encounter" designation.